Loading trending stories…
Strain-specific Ebola Vaccines to Be Trialled in DRC, WHO Announces
Back to Home

Strain-specific Ebola Vaccines to Be Trialled in DRC, WHO Announces

Capital Ethopia about 5 hours 1 mins read

Two vaccines against the deadly Bundibugyo Ebola strain gripping the Democratic Republic of Congo are set to enter trials in the outbreak’s epicentre next week, the World Health Organization announced on Tuesday. … The so-called Tumaini trial in the Democratic Republic of Congo (DRC) will test the safety, efficacy and ability to trigger an immune response. The trial uses the ring vaccination method of immunising contacts deemed to be at high risk of infection. Ervebo, a vaccine already approved for use against the more common Zaire strain of Ebola, kicked off the Tumaini trial on 23 October, at the full-scale Phase 3 level, to determine if it also offers any protection against Bundibugyo. … The two Bundibugyo-specific candidate vaccines on trial have both already passed through Phase 1 clinical trials. RFI

This article was sourced from an external publication.

Share this article
OneClick Africa Logo

Africa's premier digital hub for impactful news, entertainment, and business insights.

© 2026 OneClick Africa. All rights reserved.